Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients
Clinical trial NCT02064569 · COMPLETED
Trial details
- NCT number
- NCT02064569
- Sponsor
- GenSight Biologics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-13
- Primary completion
- 2020-06-25
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.